AQUINOX PHARMACEUTICALS INC filings

SEC filings by AQUINOX PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2019-12-20BAKER BROS. ADVISORS LPNeoleukin Therapeutics, Inc.3,802,74010.0%EDGAR
SC 13D/A2019-11-18BAKER BROS. ADVISORS LPNeoleukin Therapeutics, Inc.11,305,67929.5%EDGAR
SC 13D/A2019-08-13BAKER BROS. ADVISORS LPNeoleukin Therapeutics, Inc.11,359,67940.3%EDGAR
SC 13D/A2019-08-07BAKER BROS. ADVISORS LPAQUINOX PHARMACEUTICALS, INC11,359,67948.2%EDGAR
SC 13G/A2019-02-14PRICE T ROWE ASSOCIATES INC /MD/AQUINOX PHARMACEUTICALS, INC00.0%EDGAR
SC 13G/A2019-02-14EcoR1 Capital, LLCAQUINOX PHARMACEUTICALS, INC2,265,8809.6%EDGAR
SC 13G/A2019-01-25FRANKLIN RESOURCES INCAQUINOX PHARMACEUTICALS, INC00.0%EDGAR
SC 13G2018-07-16EcoR1 Capital, LLCAQUINOX PHARMACEUTICALS, INC1,758,9737.5%EDGAR
SC 13G/A2018-07-10PRICE T ROWE ASSOCIATES INC /MD/AQUINOX PHARMACEUTICALS, INC1,350,0005.7%EDGAR
SC 13G/A2018-02-14PRICE T ROWE ASSOCIATES INC /MD/AQUINOX PHARMACEUTICALS, INC3,375,13014.3%EDGAR
SC 13G/A2018-02-14RA CAPITAL MANAGEMENT, LLCAQUINOX PHARMACEUTICALS, INC00.0%EDGAR
SC 13G/A2018-02-05FRANKLIN RESOURCES INCAQUINOX PHARMACEUTICALS, INC1,334,6075.7%EDGAR
SC 13G/A2018-01-09BlackRock Inc.AQUINOX PHARMACEUTICALS, INC1,014,2974.3%EDGAR
SC 13D/A2017-03-27BAKER BROS. ADVISORS LPAQUINOX PHARMACEUTICALS, INC10,934,15446.7%EDGAR
SC 13G/A2017-02-14RA Capital Healthcare Fund LPAQUINOX PHARMACEUTICALS, INC00.0%EDGAR
SC 13G/A2017-02-14RA CAPITAL MANAGEMENT, LLCAQUINOX PHARMACEUTICALS, INC2,191,9779.4%EDGAR
SC 13G/A2017-02-14Visium Asset Management, LPAQUINOX PHARMACEUTICALS, INC00.0%EDGAR
SC 13G/A2017-02-09FRANKLIN RESOURCES INCAQUINOX PHARMACEUTICALS, INC1,392,2455.9%EDGAR
SC 13G/A2017-02-06PRICE T ROWE ASSOCIATES INC /MD/AQUINOX PHARMACEUTICALS, INC3,400,39714.5%EDGAR
SC 13G/A2017-01-19BlackRock Inc.AQUINOX PHARMACEUTICALS, INC1,592,3996.8%EDGAR